• 1. The versatile electrophilic reactivity of 4,6-dinitrobenzo[d]isoxazole-3-carbonitrile
  Betty Cottyn,Alexei Starosotnikov,Dominique Vichard,Régis Goumont,Svyatoslav Shevelev,Fran?ois Terrier Org. Biomol. Chem. 2009 7 1137
• 2. The versatile electrophilic reactivity of 4,6-dinitrobenzo[d]isoxazole-3-carbonitrile
  Betty Cottyn,Alexei Starosotnikov,Dominique Vichard,Régis Goumont,Svyatoslav Shevelev,Fran?ois Terrier Org. Biomol. Chem. 2009 7 1137
• 3. Syntheses with isoxazoles; the production of an isoxazolo[2,3-a]pyridinium salt, and the photochemical conversion of isoxazole-3-carboxylates into oxazole-2-carboxylates
  R. H. Good,Gurnos Jones J. Chem. Soc. C 1971 1196
• 4. Reaction of isoxazoles and isoxazolium salts with organometallic reagents. Synthesis of dihydroisoxazoles
  Angel Albertola,Luis Fernando Antolín,Ana González,Miguel Angel Laguna,Francisco José Pulido J. Chem. Soc. Perkin Trans. 1 1988 791

• Solvents and Organic Chemicals Organic Compounds Organoheterocyclic compounds Azoles Isoxazoles

Recent Advances in the Study of 1,2-Oxazole-3-carbonitrile (CAS: 68776-57-8) in Chemical Biology and Pharmaceutical Research

The compound 1,2-oxazole-3-carbonitrile (CAS: 68776-57-8) has recently garnered significant attention in the field of chemical biology and pharmaceutical research due to its versatile applications in drug discovery and development. This heterocyclic scaffold is known for its unique chemical properties, which make it a promising candidate for the synthesis of novel bioactive molecules. Recent studies have focused on exploring its potential as a key intermediate in the development of therapeutics targeting various diseases, including cancer, infectious diseases, and neurological disorders.

One of the most notable advancements in this area is the use of 1,2-oxazole-3-carbonitrile as a building block in the synthesis of kinase inhibitors. Kinases play a critical role in cell signaling pathways, and their dysregulation is often associated with cancer and other proliferative diseases. Researchers have successfully incorporated this compound into the design of selective kinase inhibitors, demonstrating its ability to enhance binding affinity and specificity. For instance, a 2023 study published in the Journal of Medicinal Chemistry highlighted the synthesis of a series of pyrazole-oxazole hybrids, where 1,2-oxazole-3-carbonitrile was utilized to improve the pharmacokinetic properties of the resulting inhibitors.

In addition to its role in kinase inhibition, 1,2-oxazole-3-carbonitrile has also been investigated for its antimicrobial properties. A recent study in the European Journal of Medicinal Chemistry reported the synthesis of novel oxazole derivatives containing the 1,2-oxazole-3-carbonitrile moiety, which exhibited potent activity against drug-resistant bacterial strains. The researchers attributed this activity to the compound's ability to disrupt bacterial cell wall synthesis, suggesting its potential as a lead compound for the development of new antibiotics.

Another exciting development is the application of 1,2-oxazole-3-carbonitrile in the field of neurodegenerative disease research. A 2022 study in ACS Chemical Neuroscience explored the compound's neuroprotective effects in models of Alzheimer's disease. The findings indicated that derivatives of 1,2-oxazole-3-carbonitrile could modulate amyloid-beta aggregation, a key pathological feature of Alzheimer's disease, thereby offering a potential therapeutic strategy for this debilitating condition.

Despite these promising findings, challenges remain in the optimization of 1,2-oxazole-3-carbonitrile-based compounds for clinical use. Issues such as solubility, metabolic stability, and toxicity need to be addressed through further structural modifications and preclinical studies. Nevertheless, the compound's versatility and demonstrated bioactivity make it a valuable tool in the ongoing quest for innovative therapeutics. Future research directions may include the exploration of its applications in other therapeutic areas, as well as the development of more efficient synthetic routes to facilitate large-scale production.

• 1369370-61-5(5-amino-1,2-oxazole-3-carbonitrile)
• 30842-90-1(3-Methylisoxazole)
• 57351-99-2(5-Methylisoxazole-3-carbonitrile)
• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)